These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27735826)

  • 1. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.
    Vila J; Teshome M; Tucker SL; Woodward WA; Chavez-MacGregor M; Hunt KK; Mittendorf EA
    Ann Surg; 2017 Mar; 265(3):574-580. PubMed ID: 27735826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment.
    Mittendorf EA; Vila J; Tucker SL; Chavez-MacGregor M; Smith BD; Symmans WF; Sahin AA; Hortobagyi GN; Hunt KK
    JAMA Oncol; 2016 Jul; 2(7):929-36. PubMed ID: 26986538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.
    Mittendorf EA; Jeruss JS; Tucker SL; Kolli A; Newman LA; Gonzalez-Angulo AM; Buchholz TA; Sahin AA; Cormier JN; Buzdar AU; Hortobagyi GN; Hunt KK
    J Clin Oncol; 2011 May; 29(15):1956-62. PubMed ID: 21482989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
    Caudle AS; Yu TK; Tucker SL; Bedrosian I; Litton JK; Gonzalez-Angulo AM; Hoffman K; Meric-Bernstam F; Hunt KK; Buchholz TA; Mittendorf EA
    Breast Cancer Res; 2012 May; 14(3):R83. PubMed ID: 22621334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.
    Fowble B; Jairam AK; Wang F; Peled A; Alvarado M; Ewing C; Esserman L; Park C; Lazar A
    Clin Breast Cancer; 2018 Feb; 18(1):e107-e113. PubMed ID: 28830795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.
    Mittendorf EA; Buchholz TA; Tucker SL; Meric-Bernstam F; Kuerer HM; Gonzalez-Angulo AM; Bedrosian I; Babiera GV; Hoffman K; Yi M; Ross MI; Hortobagyi GN; Hunt KK
    Ann Surg; 2013 Feb; 257(2):173-9. PubMed ID: 23291658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the CPS + EG Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Abdelsattar JM; Al-Hilli Z; Hoskin TL; Heins CN; Boughey JC
    Ann Surg Oncol; 2016 Oct; 23(10):3206-11. PubMed ID: 27328945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
    J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.
    Weksberg DC; Allen PK; Hoffman KE; Litton JK; Strom EA; Shah RR; Kuerer HM; Hunt KK; Buchholz TA; Mittendorf EA
    Ann Surg Oncol; 2013 Oct; 20(11):3430-7. PubMed ID: 23720073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
    Nagar H; Mittendorf EA; Strom EA; Perkins GH; Oh JL; Tereffe W; Woodward WA; Gonzalez-Angulo AM; Hunt KK; Buchholz TA; Yu TK
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):782-7. PubMed ID: 21885207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
    Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
    JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.
    Woodward WA; Strom EA; Tucker SL; Katz A; McNeese MD; Perkins GH; Buzdar AU; Hortobagyi GN; Hunt KK; Sahin A; Meric F; Sneige N; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):336-44. PubMed ID: 12957243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy.
    Marmé F; Lederer B; Blohmer JU; Costa SD; Denkert C; Eidtmann H; Gerber B; Hanusch C; Hilfrich J; Huober J; Jackisch C; Kümmel S; Loibl S; Paepke S; Untch M; von Minckwitz G; Schneeweiss A
    Eur J Cancer; 2016 Jan; 53():65-74. PubMed ID: 26693900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.
    Akay CL; Meric-Bernstam F; Hunt KK; Grubbs EG; Bedrosian I; Tucker SL; Kuerer HM; Hoffman KE; Babiera GV; Strom EA; Buchholz TA; Mittendorf EA
    Ann Surg Oncol; 2012 Mar; 19(3):901-7. PubMed ID: 21861223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.
    Huang EH; Strom EA; Perkins GH; Oh JL; Chen AM; Meric-Bernstam F; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):352-7. PubMed ID: 16887286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
    Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
    Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
    Swisher SK; Vila J; Tucker SL; Bedrosian I; Shaitelman SF; Litton JK; Smith BD; Caudle AS; Kuerer HM; Mittendorf EA
    Ann Surg Oncol; 2016 Mar; 23(3):749-56. PubMed ID: 26511263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.